Similarly, a study found that the acute effect of lamotrigine augmentation therapy for patients with treatment-resistant depressive disorder is not related to BDNF (34), suggesting the BDNF expressions show different change trends with different depressive conditions. This evidence concerns the gene BDNF and depressive disorder.